Policymakers across Latin America are stepping up efforts to distribute vaccines, with Mexico and Chile set to roll out the (approved) Pzifer/BioNTech jab within just a few weeks. However, most of the region is banking on other vaccines which have yet to be given the green light, while political infighting in Brazil adds another challenge to the roll-out of vaccines there. Meanwhile, Cuba’s battered economy will be hit with some shock therapy in the new year as the country gradually moves towards a more market-based system.
This is our last Weekly of 2020, and the next edition will be published on 8th January. To all those celebrating, Merry Christmas and Happy New Year!
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services